Latest Freenome News & Updates

See the latest news and media coverage for Freenome. We track all announcements, press releases, and industry mentions in real time, all in one place.

Freenome

Biotech company developing blood tests for early cancer detection

freenome.com

Headquarters: Brisbane, United States
Founded year: 2014
Company type: Private company
Number of employees: 410–500
Industry: Biotechnology & Medical Research

Last updated October 19

Latest news about Freenome

In short: Freenome launched SimpleScreen Lung after FDA CRC approval, Nasdaq listing and updated CRC data

Company announcements

September 29 Freenome

Freenome launches SimpleScreen CRC with Abbott

The blood-based test follows over a decade of R&D, clinical validation with 40,000 participants, and FDA approval to improve colorectal cancer screening access.

July 31 Freenome

Freenome celebrated FDA approval, IPO, and test results

The company's SimpleScreen CRC test received FDA approval, its stock began trading on Nasdaq, and an updated version showed improved detection of precancerous lesions.

July 27 Freenome

Freenome's SimpleScreen CRC receives FDA approval

Abbott will commercialize the test in the U.S., expanding colorectal cancer screening options for millions of overdue Americans.

July 20 Freenome

Freenome debuts as a publicly traded company for blood-based cancer detection

The company raised over $300 million and will trade on Nasdaq under FRNM starting July 21, 2026.

Media coverage

October 19 The Globe and Mail

Freenome Expands Cancer Screening with SimpleScreen Lung Launch

Freenome Inc ( ) has provided an announcement. On October 20, 2026, Freenome launched SimpleScreen Lung, a laboratory-developed blood-based test for adults aged 50 to...

September 29 MassDevice

Abbott rolls out SimpleScreen colorectal cancer blood test developed by Freenome

The SimpleScreen CRC blood test, developed by Freenome, will be sold exclusively by Abbott alongside its Cologuard Plus home screening exam.

July 26 Reuters

FDA approves Freenome's blood test for colorectal cancer screening

The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way for partner Abbott to launch it in the...

July 20 360dx

Freenome Goes Public in $310M SPAC Deal

The firm is developing blood-based early cancer detection tests for a variety of indications, including colorectal cancer and lung cancer.

Never miss news about Freenome

Track Freenome and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Freenome competitors & trending companies

Browse news for competitors to Freenome and other trending companies.